Compare · head to head
Champions Oncology vs Personalis
Champions Oncology ranks higher overall — 360 rank 32 vs 8.
Champions Oncology leads on Value (59 vs 33) and Quality (52 vs 14). Personalis leads on Growth (53 vs 31) and Safety (42 vs 34). The two are close on Sentiment.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | USA |
| Sector | Health Care | Health Care |
| Industry | Life Sciences Tools & Services | Life Sciences Tools & Services |
| Size | Small | Small |
| ISIN | US15870P3073 | US71535D1063 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 32 | 8 |
| Value | 59 | 33 |
| Quality | 52 | 14 |
| Growth | 31 | 53 |
| Safety | 34 | 42 |
| Sentiment | 54 | 50 |
| Quality details | ||
| Profitability | 39 | 9 |
| Cash Truth | 65 | 20 |
Champions Oncology vs Tempus AIChampions Oncology vs Charles River LaboratoriesChampions Oncology vs InotivChampions Oncology vs Cytek BiosciencesAdd a third stock →
Full analyses: Champions Oncology · Personalis
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100